(Kearns-Sayre Syndrome; Leigh’s Syndrome; Mitochondrial DNA Depletion Syndrome; Mitochondrial Encephalomyopathy, Lactic Acidosis and Strokelike Episodes; Myoclonic Epilepsy Associated With Ragged Red Fibers; Mitochondrial Neurogastrointestinal Encephalopathy; Neuropathy, Ataxia, and Retinitis Pigmentosa; Pearson’s Syndrome; Progressive External Ophthalmoplegia)
|Muscular and Nervous Systems|
|Mitochondrial myopathies decrease the ability of nerves and muscles. Weakness and uncoordinated movement may result.|
|Copyright © Nucleus Medical Media, Inc.|
|NAME OF CONDITION||AGE OF ONSET||DEFINING SYMPTOMS|
|Kearns-Sayre syndrome (KSS)||Before age 20||Salt and pepper pigmentation in eye, eye movement problems (PEO), heart and skeletal muscle dysfunction|
|Leigh’s syndrome||Infancy—can appear later||Brain abnormalities that lead to muscle problems, seizures, uncoordinated muscle movement (ataxia), impaired vision and hearing, developmental delay, and poor control over breathing|
|Mitochondrial DNA depletion syndrome||Infancy||Muscle weakness and liver failure, floppiness, feeding difficulties, and developmental delay|
|Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS)||Childhood to adulthood||Stroke-like episodes, migraine headaches, vomiting and seizures, muscle weakness, exercise intolerance, hearing loss, diabetes, short stature|
|Myoclonic epilepsy associated with ragged red fibers (MERRF)||Late childhood to adulthood||Myoclonus (jerky movements), seizures, muscle weakness, uncoordinated muscle movement (ataxia)|
|Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)||Before age 20||Eye movement problems (PEO), drooping eyelid, limb weakness, digestive problems, peripheral neuropathy|
|Neuropathy, ataxia, and retinitis pigmentosa (NARP)||Early childhood to adulthood||Uncoordinated muscle movement (ataxia), degeneration of the retina in the eye leading to loss of vision|
|Pearson’s syndrome||Infancy||Causes severe anemia and pancreas problems, survivors usually develop KSS|
|Progressive external ophthalmoplegia (PEO)||Adulthood||Eye movement difficulty, and often symptoms of other mitochondrial diseases, but can be an independent syndrome|
- Muscle biopsy
- Blood tests
- Lumbar puncture—to evaluate the cerebrospinal fluid that protects the brain and spinal cord
Muscular Dystrophy Association http://www.mda.org
National Institute of Neurological Disorders and Stroke http://www.ninds.nih.gov
Canadian Institutes of Health Research http://www.cihr-irsc.gc.ca
Muscle Dystrophy Canada http://www.muscle.ca
DiMauro S. Pathogenesis and treatment of mitochondrial myopathies: recent advances. Acta Myol. 2010;29(2):333-338.
Facts about mitochondrial myopathies. Muscular Dystrophy Association website. Available at: http://www.mda.org/publications/mitochondrial%5Fmyopathies.html. Published December 2009. Accessed August 20, 2014.
Jacobs L, Wert GD, et al. The transmission of OXPHOS disease and methods to prevent this. Hum Reprod Update. 2006;12(2):119-136.
Mitochondrial myopathies. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated December 2, 2013. Accessed August 20, 2014.
NINDS mitochondrial myopathies page. National Institute of Neurological Disorders and Stroke website. Available at: http://www.ninds.nih.gov/disorders/mitochondrial%5Fmyopathy/mitochondrial%5Fmyopathy.htm. Updated December 16, 2011. Accessed August 20, 2014.
- Reviewer: Michael Woods, MD
- Review Date: 08/2014 -
- Update Date: 00/51/2013 -
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © EBSCO Publishing
All rights reserved.